Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Z Gastroenterol ; 54(9): 1081-4, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27612222

ABSTRACT

We report the case of a 59-year-old patient who accidentally underwent live vaccination against yellow fever during continuous treatment with the TNF-α-antibody (AB) infliximab for ulcerative colitis. The clinical course showed fever of short duration and elevation of liver enzymes without further clinical complications. Yellow fever viremia was not detectable and protective antibodies were developed. A primary vaccination against yellow fever under infliximab has not been reported in the literature before, although vaccination is an important topic in IBD. Live vaccinations, like Stamaril(®) against yellow fever, are contraindicated during TNF-α-AB treatment. Treatment regimens containing TNF-α-AB are of growing importance, not only in gastroenterology, but also in rheumatology and dermatology. We discuss this topic by presenting our case and reviewing the current literature.


Subject(s)
Colitis, Ulcerative/complications , Colitis, Ulcerative/drug therapy , Infliximab/administration & dosage , Yellow Fever Vaccine/administration & dosage , Yellow Fever/chemically induced , Contraindications , Diagnosis, Differential , Gastrointestinal Agents/administration & dosage , Humans , Male , Middle Aged , Treatment Outcome , Yellow Fever/diagnosis , Yellow Fever/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...